Analysis of HIV-1 clinical trials: statistical magic?
- 1 June 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9169) , 2061-2064
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trialAIDS, 1999
- HIV-1 RNA, CD4 cell count and the risk of progression to AIDS and death during treatment with HIV-1 reverse transcriptase inhibitorsAIDS, 1998
- Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapyAIDS, 1998
- 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individualsThe Lancet, 1998
- Antiretroviral Therapy for HIV Infection in 1998JAMA, 1998
- Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 InfectionJAMA, 1998
- Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patientsAIDS, 1998
- HIV-1 dynamics after transient antiretroviral therapy: Implications for pathogenesis and clinical managementJournal of Medical Virology, 1997
- Predictors and Impact of Patients Lost to Follow-Up in a Long-Term Randomized Trial of Immediate Versus Deferred Antiretroviral TreatmentJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 InfectionAnnals of Internal Medicine, 1997